This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Melanomas of skin
  • /
  • Long-Term Outcomes in Patients With BRAF V600-Muta...
Journal

Long-Term Outcomes in Patients With BRAF V600-Mutant Metastatic Melanoma Who Received Dabrafenib Combined With Trametinib.

Read time: 1 mins
Published:9th Oct 2017
Author: Long GV, Eroglu Z, Infante J, Patel S, Daud A, Johnson DB et al.
Availability: Pay for access, or by subscription
Ref.:J Clin Oncol. 2017:JCO2017741025.
DOI:10.1200/JCO.2017.74.1025
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest